Your browser doesn't support javascript.
loading
Brachytherapy for uterine cervix-limited acute myeloid leukemia relapse.
Beziat, Guillaume; Tavitian, Suzanne; Arnaud, Francois-Xavier; Izar, Françoise; Attal, Justine; Borel, Cécile; Recher, Christian; Ducassou, Anne.
Afiliación
  • Beziat G; Hematology Department, Institut Universitaire du Cancer de Toulouse - Oncopole, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
  • Tavitian S; Hematology Department, Institut Universitaire du Cancer de Toulouse - Oncopole, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
  • Arnaud FX; Engineering and Medical Physics Department, Institut Universitaire du Cancer de Toulouse - Oncopole, Institut Claudius Regaud, F-31000 Toulouse, France.
  • Izar F; Radiation Oncology and Brachytherapy Department, Institut Universitaire du Cancer de Toulouse - Oncopole, Institut Claudius Regaud, F-31000 Toulouse, France.
  • Attal J; Radiation Oncology and Brachytherapy Department, Institut Universitaire du Cancer de Toulouse - Oncopole, Institut Claudius Regaud, F-31000 Toulouse, France.
  • Borel C; Hematology Department, Institut Universitaire du Cancer de Toulouse - Oncopole, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
  • Recher C; Hematology Department, Institut Universitaire du Cancer de Toulouse - Oncopole, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France.
  • Ducassou A; Radiation Oncology and Brachytherapy Department, Institut Universitaire du Cancer de Toulouse - Oncopole, Institut Claudius Regaud, F-31000 Toulouse, France.
J Contemp Brachytherapy ; 14(6): 601-604, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36819473
ABSTRACT
Acute myeloid leukemia (AML) may extend to extra-medullary sites at diagnosis or at relapse, either isolated or associated with bone marrow disease. Granulocytic sarcoma of uterine cervix is rare, and there is no established treatment for this disease. Two cases of uterine cervix-limited AML relapse showed that brachytherapy may be an effective therapeutic option in this setting along with chemotherapy, with good tolerance.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Contemp Brachytherapy Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Contemp Brachytherapy Año: 2022 Tipo del documento: Article País de afiliación: Francia